Raida Al‐Kassas

2.1k total citations
39 papers, 1.6k citations indexed

About

Raida Al‐Kassas is a scholar working on Pharmaceutical Science, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Raida Al‐Kassas has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmaceutical Science, 14 papers in Molecular Biology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Raida Al‐Kassas's work include Advanced Drug Delivery Systems (20 papers), Advancements in Transdermal Drug Delivery (9 papers) and Drug Solubulity and Delivery Systems (7 papers). Raida Al‐Kassas is often cited by papers focused on Advanced Drug Delivery Systems (20 papers), Advancements in Transdermal Drug Delivery (9 papers) and Drug Solubulity and Delivery Systems (7 papers). Raida Al‐Kassas collaborates with scholars based in New Zealand, United Kingdom and Australia. Raida Al‐Kassas's co-authors include Ali Seyfoddin, John Shaw, Mahima Bansal, Andrew N. Shelling, Annette Lasham, Raid G. Alany, Zimei Wu, Hamdy Abdelkader, Sanjay Garg and Jingyuan Wen and has published in prestigious journals such as Journal of Controlled Release, Carbohydrate Polymers and International Journal of Pharmaceutics.

In The Last Decade

Raida Al‐Kassas

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raida Al‐Kassas New Zealand 19 818 417 389 261 233 39 1.6k
Ángela Machado de Campos Brazil 17 784 1.0× 377 0.9× 458 1.2× 346 1.3× 138 0.6× 35 1.5k
Shaila A. Lewis India 26 1.0k 1.2× 473 1.1× 264 0.7× 213 0.8× 213 0.9× 94 2.0k
Yıldız Özsoy Türkiye 24 862 1.1× 325 0.8× 363 0.9× 149 0.6× 217 0.9× 82 1.8k
Musarrat Husain Warsi Saudi Arabia 25 746 0.9× 477 1.1× 305 0.8× 162 0.6× 224 1.0× 81 1.8k
Srividya Gorantla India 27 880 1.1× 349 0.8× 245 0.6× 260 1.0× 165 0.7× 38 1.7k
Neslihan Üstündağ Okur Türkiye 22 993 1.2× 295 0.7× 473 1.2× 340 1.3× 254 1.1× 98 2.1k
Shikha Dhawan India 20 518 0.6× 288 0.7× 398 1.0× 280 1.1× 221 0.9× 44 1.8k
Vamshi Krishna Rapalli India 28 1.0k 1.3× 429 1.0× 244 0.6× 250 1.0× 157 0.7× 34 2.0k
Shihui Yu China 23 731 0.9× 275 0.7× 377 1.0× 274 1.0× 283 1.2× 44 1.6k
Mohd Abul Kalam Saudi Arabia 26 908 1.1× 558 1.3× 366 0.9× 457 1.8× 174 0.7× 88 2.1k

Countries citing papers authored by Raida Al‐Kassas

Since Specialization
Citations

This map shows the geographic impact of Raida Al‐Kassas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raida Al‐Kassas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raida Al‐Kassas more than expected).

Fields of papers citing papers by Raida Al‐Kassas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raida Al‐Kassas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raida Al‐Kassas. The network helps show where Raida Al‐Kassas may publish in the future.

Co-authorship network of co-authors of Raida Al‐Kassas

This figure shows the co-authorship network connecting the top 25 collaborators of Raida Al‐Kassas. A scholar is included among the top collaborators of Raida Al‐Kassas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raida Al‐Kassas. Raida Al‐Kassas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ross, Kehinde, et al.. (2021). Chitosan nanoparticles for enhancing drugs and cosmetic components penetration through the skin. European Journal of Pharmaceutical Sciences. 160. 105765–105765. 93 indexed citations
2.
Lasham, Annette, et al.. (2017). Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells. Materials Science and Engineering C. 76. 593–600. 86 indexed citations
3.
Al‐Kassas, Raida, Mahima Bansal, & John Shaw. (2017). Nanosizing techniques for improving bioavailability of drugs. Journal of Controlled Release. 260. 202–212. 153 indexed citations
4.
Rupenthal, Ilva D., et al.. (2015). Ocular delivery systems for topical application of anti-infective agents. Drug Development and Industrial Pharmacy. 42(1). 1–11. 43 indexed citations
5.
Swift, Simon, et al.. (2015). Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery. Pharmaceutical Development and Technology. 21(2). 172–179. 43 indexed citations
6.
Lasham, Annette, et al.. (2015). Nanoparticle therapeutics: Technologies and methods for overcoming cancer. European Journal of Pharmaceutics and Biopharmaceutics. 97(Pt A). 140–151. 66 indexed citations
7.
Tharkar, Priyanka, et al.. (2014). Nanoparticulate carriers: an emerging tool for breast cancer therapy. Journal of drug targeting. 23(2). 97–108. 20 indexed citations
8.
Al‐Kassas, Raida, et al.. (2013). Analytical Profile of Moxidectin. PubMed. 38. 315–366. 13 indexed citations
9.
Svirskis, Darren, et al.. (2013). Development of mucoadhesive floating hollow beads of acyclovir with gastroretentive properties. Pharmaceutical Development and Technology. 19(5). 571–576. 18 indexed citations
11.
Al‐Kassas, Raida, et al.. (2012). Separation and identification of degradation products in eprinomectin formulation using LC, LTQ FT-MS, H/D exchange, and NMR. Journal of Pharmaceutical and Biomedical Analysis. 63. 62–73. 18 indexed citations
12.
Abdelkader, Hamdy, Sayed Ismail, Amal K. Hussein, et al.. (2012). Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models. International Journal of Pharmaceutics. 432(1-2). 1–10. 78 indexed citations
13.
Shelling, Andrew N., et al.. (2012). Nanocarrier systems for delivery of siRNA to ovarian cancer tissues. Expert Opinion on Drug Delivery. 9(7). 743–754. 5 indexed citations
14.
15.
Al‐Kassas, Raida, et al.. (2012). Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMR. Analytical and Bioanalytical Chemistry. 404(8). 2203–2222. 16 indexed citations
16.
Abdelkader, Hamdy, Zimei Wu, Raida Al‐Kassas, & Raid G. Alany. (2012). Niosomes and discomes for ocular delivery of naltrexone hydrochloride: Morphological, rheological, spreading properties and photo-protective effects. International Journal of Pharmaceutics. 433(1-2). 142–148. 75 indexed citations
17.
Seyfoddin, Ali, John Shaw, & Raida Al‐Kassas. (2010). Solid lipid nanoparticles for ocular drug delivery. Drug Delivery. 17(7). 467–489. 188 indexed citations
18.
Al‐Kassas, Raida, et al.. (2007). Controlling of systemic absorption of gliclazide through incorporation into alginate beads. International Journal of Pharmaceutics. 341(1-2). 230–237. 105 indexed citations
19.
Al‐Kassas, Raida. (2004). Design andin vitroevaluation of gentamicin–Eudragit microspheres intended for intra-ocular administration. Journal of Microencapsulation. 21(1). 71–81. 13 indexed citations
20.
Al‐Kassas, Raida, et al.. (2000). Stability studies of aspirin–magaldrate double layer tablets. Pharmaceutica Acta Helvetiae. 74(4). 351–360. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026